Clinical Trials Logo

Clinical Trial Summary

Since 1991, idiopathic macular holes (MH) can benefit from an effective treatment initially involving pars plana vitrectomy, stripping of epiretinal membranes and intraocular gas tamponade followed by facedown positioning. The initial 58% success rate has further increased to 85-100% with internal limiting membrane (ILM) peeling. However, complete ILM removal has been shown to lead to anatomic changes causing the retina to have the appearance of a dissociated optic nerve fiber layer (DONFL). Moreover, it has been associated with decreased retinal sensitivity that may cause visual discomfort despite good visual acuity. Nawrocki et al. recently suggested to reduce the area of peeled ILM (temporal inverted ILM flap technique) in order to minimize iatrogenic trauma while maintaining satisfactory surgical outcomes. The aim of this study is to compare the incidence of DONFL appearance and retinal sensitivity after macular hole surgery in eyes that underwent temporal inverted ILM flap technique and eyes that had complete ILM peeling


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03287102
Study type Interventional
Source Central Hospital, Nancy, France
Contact Jean-Baptiste CONART
Phone +33383155203
Email jbconart@hotmail.com
Status Not yet recruiting
Phase N/A
Start date February 1, 2018
Completion date February 1, 2020

See also
  Status Clinical Trial Phase
Completed NCT05287269 - Ocular Coherence Tomography During Cataract Assessment
Completed NCT04859556 - Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study N/A
Completed NCT01162356 - Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study N/A
Active, not recruiting NCT03528122 - Amniotic Membrane for Recurrent Macular Hole N/A